Concepedia

Gernot Guderian

GG

Statistics

Publications

4

Citations

414

H-Index

4

Active since

2010

Affiliations

Novartis (Germany)(Current)

Goethe University Frankfurt

University Hospital Frankfurt

Klinikum Chemnitz

Gernot Guderian is an author at Novartis (Germany) specializing in oncology, renal cell carcinoma, and metastasis.

Publications per year

2010–2015

4

Publications

4

Plk4 <i>trans</i>-autophosphorylation regulates centriole number by controlling βTrCP-mediated degradation

Gernot Guderian, Jens Westendorf, Andreas Uldschmid et al. · Journal of Cell Science · 2010 · 219 citations

Life Sciences, Cell Biology, Molecular Biology +15

RioK1, a New Interactor of Protein Arginine Methyltransferase 5 (PRMT5), Competes with pICln for Binding and Modulates PRMT5 Complex Composition and Substrate Specificity

Gernot Guderian, Christoph Peter, Julia Wiesner et al. · Journal of Biological Chemistry · 2010 · 160 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Everolimus for patients with metastatic renal cell carcinoma refractory to anti-VEGF therapy: Results of a pooled analysis of non-interventional studies

Laurence Albigès, Ulrich Kube, Jean‐Christophe Eymard et al. · European Journal of Cancer · 2015 · 20 citations

Medicine, Nephrology, Oncology +16

Everolimus in Metastatic Renal Cell Carcinoma after Failure of Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFr-TKI) Therapy: Results of an Interim Analysis of a Non-Interventional Study

Lothar Bergmann, Peter J. Goebell, Ulrich Kube et al. · Oncology Research and Treatment · 2013 · 15 citations · Full text

Medicine, Oncology, Pharmacology +17

1–4 of 4